Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]

Affiliations

• ¹ Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
• ² Gladstone Institute of Neurological Disease, University of California, San Francisco, San Francisco, CA, USA.
• ³ Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
• ⁴ Institute for Biomedical Engineering, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland.
• ⁵ Inflammation Research Unit, Division of Internal Medicine, University Hospital Zurich, Zurich, Switzerland.
• ⁶ Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
• ⁷ Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
• ⁸ Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Department of Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland.
• ⁹ Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland; Zurich Neuroscience Center (ZNZ), Zurich, Switzerland. Electronic address: [email protected].